See also this year's filing and all EDGAR filings for this company.
PDF Report 0001768446_2022_Eliem_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001768446')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2': 2, '100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 12}} |
Graph
Absolute values for 0001768446, Eliem Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 148,252,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 24,989,000 |
| 4 | LiabilitiesCurrent | 6,031,000 |
| 5 | LiabilitiesNoncurrent | 7,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,350,000 |
| 9 | ResearchAndDevelopmentExpense | 22,046,000 |
| 10 | remainder_Expenses | 1,276,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -11,808,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 173,241,000 |
| 1 | Liabilities | 6,038,000 |
| 2 | Expenses | 35,672,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 167,203,000 |
| 5 | NetIncome | -47,480,000 |
| 6 | ComprehensiveNetIncome | -47,480,000 |
| 7 | BaseVar | 113,379,500 |
| 8 | EconomicCapitalRatio | 2.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
